These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35101454)

  • 1. Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes.
    Triveri A; Sanchez-Martin C; Torielli L; Serapian SA; Marchetti F; D'Acerno G; Pirota V; Castelli M; Moroni E; Ferraro M; Quadrelli P; Rasola A; Colombo G
    J Mol Biol; 2022 Sep; 434(17):167468. PubMed ID: 35101454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
    Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
    Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics-based community analysis and perturbation response scanning of allosteric interaction networks in the TRAP1 chaperone structures dissect molecular linkage between conformational asymmetry and sequential ATP hydrolysis.
    Verkhivker GM
    Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):899-912. PubMed ID: 29684503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
    Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
    Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives.
    Serapian SA; Sanchez-Martín C; Moroni E; Rasola A; Colombo G
    Trends Pharmacol Sci; 2021 Jul; 42(7):566-576. PubMed ID: 33992469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.
    Goode KM; Petrov DP; Vickman RE; Crist SA; Pascuzzi PE; Ratliff TL; Davisson VJ; Hazbun TR
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1992-2006. PubMed ID: 28495207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Mechanisms of Allosteric Regulation and Communication Switching in the Multiprotein Regulatory Complexes of the Hsp90 Chaperone with Cochaperones and Client Proteins: Atomistic Insights from Integrative Biophysical Modeling and Network Analysis of Conformational Landscapes.
    Verkhivker GM
    J Mol Biol; 2022 Sep; 434(17):167506. PubMed ID: 35202628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates the Diversity of Protein Responses and Ligand-Specific Functional Mechanisms.
    Astl L; Stetz G; Verkhivker GM
    J Chem Theory Comput; 2020 Oct; 16(10):6656-6677. PubMed ID: 32941034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
    Ferraro M; D'Annessa I; Moroni E; Morra G; Paladino A; Rinaldi S; Compostella F; Colombo G
    J Med Chem; 2019 Jan; 62(1):60-87. PubMed ID: 30048133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands.
    Vettoretti G; Moroni E; Sattin S; Tao J; Agard DA; Bernardi A; Colombo G
    Sci Rep; 2016 Apr; 6():23830. PubMed ID: 27032695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands.
    Sattin S; Tao J; Vettoretti G; Moroni E; Pennati M; Lopergolo A; Morelli L; Bugatti A; Zuehlke A; Moses M; Prince T; Kijima T; Beebe K; Rusnati M; Neckers L; Zaffaroni N; Agard DA; Bernardi A; Colombo G
    Chemistry; 2015 Sep; 21(39):13598-608. PubMed ID: 26286886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug.
    Hu S; Ferraro M; Thomas AP; Chung JM; Yoon NG; Seol JH; Kim S; Kim HU; An MY; Ok H; Jung HS; Ryu JH; Colombo G; Kang BH
    J Med Chem; 2020 Mar; 63(6):2930-2940. PubMed ID: 32068404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1.
    Ferraro M; Moroni E; Ippoliti E; Rinaldi S; Sanchez-Martin C; Rasola A; Pavarino LF; Colombo G
    J Phys Chem B; 2021 Jan; 125(1):101-114. PubMed ID: 33369425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90.
    Rehn A; Moroni E; Zierer BK; Tippel F; Morra G; John C; Richter K; Colombo G; Buchner J
    J Mol Biol; 2016 Nov; 428(22):4559-4571. PubMed ID: 27663270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design.
    Verkhivker GM; Dixit A; Morra G; Colombo G
    Curr Top Med Chem; 2009; 9(15):1369-85. PubMed ID: 19860735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors.
    Verkhivker GM
    Methods Mol Biol; 2018; 1709():253-273. PubMed ID: 29177665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Hsp90 is a ligand-activated molecular chaperone coupling ATP binding to dimer closure through a coiled-coil intermediate.
    Sung N; Lee J; Kim JH; Chang C; Joachimiak A; Lee S; Tsai FT
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2952-7. PubMed ID: 26929380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand Binding, Unbinding, and Allosteric Effects: Deciphering Small-Molecule Modulation of HSP90.
    D'Annessa I; Raniolo S; Limongelli V; Di Marino D; Colombo G
    J Chem Theory Comput; 2019 Nov; 15(11):6368-6381. PubMed ID: 31538783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.